Also, considering ZFP14's role as a downstream target of TP53,14 it is plausible that multiple factors contribute to ZFP14's aberrant expression in ccRCC, not just m6A dysregulation. The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.